Clinical Trials Directory

Trials / Unknown

UnknownNCT04357223

NOGO for an Overactive Bladder

A Parallel, Randomised, Double Blind, Placebo Controlled Study to Investigate the Effect of NOGO on Overactive Bladder in Men and Women

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
SagaNatura · Industry
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This is a double-blind, randomized and placebo-controlled study to evaluate the safety and effectiveness of NoGo, a standardized extract from Angelica archangelica, on overactive bladder

Conditions

Interventions

TypeNameDescription
DRUGextract from Angelica archangelica leafA standardized extract from Angelica archangelica leaf. Capsule, Twice Daily
DRUGPlaceboPlacebo

Timeline

Start date
2020-05-01
Primary completion
2021-02-01
Completion
2021-03-01
First posted
2020-04-22
Last updated
2020-11-12

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04357223. Inclusion in this directory is not an endorsement.